Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung Maeng, Jay A. Berzofsky, Svetlana Pack et al.|Frontiers in Oncology|2021Cited by 26